Follow The Filings

BBWI Bath & Body Works

Bath & Body Works earnings company data as of 4:49 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 19 Nov EPS 0.11 — —
Rev — — —
FY2026 Q2 26 Aug EPS 0.24 — —
Rev — — —

Insider trades

Open-market buys and sales by BBWI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BBWI insider trades
  • $1M bought by 6 insiders
  • $14 sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Sarah E Nash Director
    Sale
    $14 1 share at $20.56 <0.1% of stake
    Traded Oct 16 Filed Oct 20
  2. James Kevin Symancyk Director
    Buy
    $351K 22,500 shares at $15.58 +126% to stake
    Traded Nov 24, 2025 Filed Nov 25, 2025
  3. Sarah E Nash Director
    Buy
    $156K 10,000 shares at $15.58 +3.6% to stake
    Traded Nov 24, 2025 Filed Nov 25, 2025
  4. Steven E Voskuil Director
    Buy
    $301K 20,000 shares at $15.04 +144% to stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
  5. Stephen D Steinour Director
    Buy
    $100K 6,700 shares at $14.86 +16% to stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
  6. Francis Hondal Director
    Buy
    $50K 3,343 shares at $15.00 +18% to stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
  7. Lucy Brady Director
    Buy
    $50K 3,470 shares at $14.40 +25% to stake
    Traded Nov 21, 2025 Filed Nov 24, 2025

Also filed in the last 12 months, not counted as buying or selling: 15 stock grants and 4 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K 5.02,9.01
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 5.07
8-K 2.02,5.02,7.01,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
DEF 14A
DEFA14A
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-K ANNUAL REPORT
8-K 2.02,7.01,9.01
8-K 7.01,9.01
8-K 5.02,9.01
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.